NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: 8TV) a premier artificial intelligence (AI) company that is transforming clinical trials in the ...
News Medical on MSN4d
New UVA clinical trial explores AI-powered insulin delivery for better diabetes careFor people living with Type 1 Diabetes, keeping blood sugar levels in check is a constant challenge. A new clinical trial at ...
GlobalData on MSN2d
MediWound commences Phase III trial for venous leg ulcers treatmentMediWound has commenced a pivotal, multicentre Phase III VALUE trial to assess its bioactive debridement therapy, EscharEx, ...
BOSTON, MA, UNITED STATES, February 13, 2025 /EINPresswire / -- When Ruihua Liu founded Hill Research, the goal was clear: to revolutionize clinical trials using Generative AI. With a background in ...
Research Triangle Park, North Carolina Saturday, February 15, 2025, 17:00 Hrs [IST] ...
Newronika, a global leader in advanced deep brain stimulation, is pleased to announce the successful closing of its €13.6 ...
Newronika announced today that it closed a €13.6 million ($14.1 million) Series B round to support its deep brain stimulation ...
Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closureInterim analysis planned ...
As we continue to discuss and tackle the problem of underrepresentation in clinical trials, we are also expanding our scope of involvement and inclusivity. The conversations are becoming broader ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback